MSI-H in CRC is associated with pathological features such as mucinous carcinoma, proximal colon, poorly differentiation, lymphatic invasion, tumor staging, tumor size, KRAS mutation, and BRAFV600E mutation (2, 6); some results of our study are consistent with these findings. Here, KRAS is linked to colorectal carcinoma.